Julian Adams is a director of Elicio Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Gamida Cell Ltd.
2 Feb 24
4
Elicio Therapeutics, Inc.
29 Dec 23
4/A
Gamida Cell Ltd.
20 Oct 23
3
Elicio Therapeutics, Inc.
7 Jun 23
4
Gamida Cell Ltd.
10 Feb 23
4
Gamida Cell Ltd.
22 Nov 22
4
Gamida Cell Ltd.
10 Aug 22
3
Gamida Cell Ltd.
3 Jan 22
3
Neon Therapeutics, Inc.
26 Jun 18
4
PIERIS PHARMACEUTICALS, INC.
29 Jan 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 423,750 |
28 Dec 23 | ELTX Elicio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 4,100 | 33.87 k | 4,100 |
19 Oct 23 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 28,300 | 0.00 | 223,750 |
19 Oct 23 | GMDAQ Gamida Cell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 1.59 | 56,600 | 89.99 k | 56,600 |
8 Feb 23 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 28,300 | 0.00 | 223,750 |
8 Feb 23 | GMDAQ Gamida Cell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 1.59 | 56,600 | 89.99 k | 56,600 |